doi: 10.3389/fphar.2023.1122632 Received 13 December 2022 Accepted 13 March 2023 Published 27 March 2023 Volume 14 - 2023 Edited by Enrico Sangiovanni, University of Milan, Italy Reviewed by Ayaz Shahid, Western University of Health Sciences, United States Andres A
Just amazed at the quality and overall experience
GHK-Cu demonstrates activity at nanomolar concentrations, levels millions of times lower than typical product percentages
It suggests that glutathione and other antioxidants, far from interfering with the activity of chemotherapy, appear to reduce side effects without decreasing efficacy and may, in fact, improve the efficacy of the chemotherapy in fighting cancer
Binding of p53 to the KIX domain of CREB binding protein
Epithalon appears to favorably affect overall health and address specific diseases, as well